10-Q: Universal Corp. Q2 Earnings Rise, Tobacco Strong, Ingredients Face Headwinds

Universal Corporation reports increased net income and diluted EPS for Q2 and H1 FY26, driven by solid Tobacco Operations, despite challenges in Ingredients and higher operating costs.

Summary

• Net income attributable to Universal Corporation increased by 32% to $34.169 million for the three months ended September 30, 2025, compared to $25.940 million in the prior year.
• Diluted earnings per share (EPS) rose by 32% to $1.36 for the three months ended September 30, 2025, up from $1.03 in the prior year.
• Consolidated sales and other operating revenues grew by 6% to $754.177 million for the three months ended September 30, 2025, compared to $710.762 million in the prior year.
• Consolidated operating income decreased by 2% to $67.649 million for the three months ended September 30, 2025, down from $68.736 million in the prior year.
• Tobacco Operations segment revenue increased by 5% to $659.4 million for the quarter, driven by a 3% increase in tobacco sales volumes, but operating income for the segment decreased by 16% to $65.2 million.
• Ingredients Operations segment revenue increased by 18% to $94.8 million for the quarter, but operating income for the segment decreased by 112% to a loss of $0.2 million.
• A material weakness in internal control over financial reporting was identified at a tobacco subsidiary related to the documentation and execution of controls for physical inventory counts and reconciliation.
• The company received a final and indisputable favorable ruling in July 2025 from the Brazilian National Treasury Attorney's office regarding a Parana VAT assessment, requiring the state to withdraw all claims.

Sentiment

Score: 6

Explanation: The company delivered strong net income and EPS growth, primarily driven by its robust Tobacco Operations and a favorable tax ruling. However, the decline in quarterly consolidated operating income, the significant profitability challenges in the Ingredients segment, and the disclosed material weakness in internal controls introduce notable concerns and risks, leading to a mixed sentiment.

Positives

• Net income attributable to Universal Corporation increased significantly by 32% for the quarter and 64% for the six-month period year-over-year.
• Diluted EPS saw substantial growth, rising 32% for the quarter and 63% for the six-month period.
• Consolidated revenue increased by 6% for the quarter and 3% for the six-month period.
• Tobacco Operations segment achieved solid results with a 5% increase in quarterly revenue and a 10% increase in six-month operating income, driven by higher sales volumes and a favorable product mix.
• Current crop tobacco shipments are progressing smoothly and earlier than in the prior fiscal year.
• Ingredients Operations segment maintained positive momentum with higher sales volumes, increasing revenue by 18% for the quarter and 11% for the six-month period.
• A final and indisputable favorable ruling was issued in July 2025, declaring a significant Brazilian VAT assessment without merit, requiring the state to withdraw all claims against the company's subsidiary.
• Interest expense decreased by 4% in the quarter and 9% in the six-month period due to lower interest rates and debt balances.
• Uncommitted tobacco inventory levels remained low at approximately 13% of total tobacco inventory as of September 30, 2025, indicating effective inventory management.
• The company is in compliance with all financial covenants of its debt agreements as of September 30, 2025, and has no long-term debt maturing until fiscal year 2028.
• Expanded use of clean electricity and on-site solar installations in Italy, the Dominican Republic, and the Philippines demonstrates progress in sustainability efforts.

Negatives

• Consolidated operating income decreased by 2% for the three months ended September 30, 2025, compared to the prior year.
• Gross profit margin percentage declined by 160 basis points to 18.5% for the three months ended September 30, 2025.
• Selling, general and administrative expenses increased by 13% for the quarter and 6% for the six-month period.
• Tobacco Operations segment operating income decreased by 16% for the quarter due to unfavorable foreign currency comparisons ($5.1 million), higher inventory write-downs ($4.0 million), and increased provisions for farmer advances ($2.0 million).
• Ingredients Operations segment operating income decreased significantly by 112% for the quarter (resulting in a loss) and 64% for the six-month period, impacted by product mix, higher fixed costs (including depreciation from expanded facilities), higher inventory write-downs ($3.5 million in Q2), weakness in the consumer-packaged goods industry, and tariff uncertainty.
• Net cash used by operating activities increased substantially to $172.4 million for the six months ended September 30, 2025, an increase of $124.9 million compared to the prior year, primarily due to lower working capital requirements in the prior period.
• A material weakness in internal control over financial reporting was identified at a tobacco subsidiary, indicating a reasonable possibility of material misstatement not being prevented or detected timely.

Risks

• Product purchased not meeting quality and quantity requirements.
• Reliance on a few large customers.
• Anticipated levels of demand for and supply of products and services.
• Tobacco growing conditions and customer requirements.
• Major shifts in customer requirements for leaf tobacco.
• Higher inflation rates, tariffs, and other pressures on costs.
• Weather and other conditions.
• Exposure to certain legal, regulatory, and financial risks related to climate change.
• Industry-specific risks related to plant-based ingredients businesses.
• Disruption of the supply chain for plant-based ingredients.
• Success in pursuing strategic investments or acquisitions and integration of new businesses and the impact of these new businesses on future results.
• Inability to maintain effective information technology systems and safeguard confidential information.
• Inability to attract, develop, retain, motivate, and maintain good relationships with the workforce.
• Dependence on a seasonal workforce.
• Epidemics, pandemics, or similar widespread public health concerns.
• Government efforts to regulate the production and consumption of tobacco products.
• Government actions on the sourcing of leaf tobacco.
• Economic and political conditions in the countries in which the company and its customers operate, including the ongoing impacts from international conflicts.
• Sustainability considerations from governments and other stakeholders.
• Changes in tax laws in the countries where the company does business.
• Material weaknesses in internal control over financial reporting.
• Inability to use a Form S-3 registration statement.
• Failure of customers or suppliers to repay extensions of credit.
• Changes in exchange rates.
• Changes in interest rates.
• Low investment performance by defined benefit pension plan assets and changes in pension plan valuation assumptions.
• The company cannot assure when the material weakness in internal control over financial reporting will be remediated, whether additional actions will be required, or the costs of any such actions.
• The company cannot assure that additional material weaknesses will not arise in the future.
• Legal and tax matters, if resolved adversely to management's current expectation, could have a material adverse effect on the company's results of operations for a particular fiscal reporting period.

Future Outlook

The company expects to spend approximately $45 to $55 million on capital projects for maintenance and growth over the next twelve months. Additional pension contributions of $1.6 million and stock-based compensation expense of $1.6 million are anticipated for the remaining six months of fiscal year 2026. Management does not foresee a material impact on financial statements from the Pillar Two legislation in fiscal year 2026 or from the recently signed One Big Beautiful Bill Act (OBBBA). Available capital resources are projected to sufficiently cover normal working capital needs and anticipated capital expenditures for the next twelve months and beyond.

Management Comments

• Our Tobacco Operations segment achieved solid results in the six months and quarter.
• Customer demand has remained firm following several years of undersupply, despite significantly larger tobacco crops.
• Shipments are progressing smoothly, and current crop tobacco is being shipped earlier than in fiscal year 2025.
• Overall, we believe the segment has once again demonstrated effective management in navigating market dynamics.
• Our Ingredients Operations segment maintained positive momentum, achieving higher sales and volume in both the quarter and six months ended September 30, 2025, as compared to the respective prior fiscal year periods.
• Continued interest in new value-added products has translated into an active pipeline, supported by Universal Ingredients' enhanced production and operational capabilities.
• We believe the segment continues to be well-positioned to capitalize on its investments and drive future growth.
• We generally do not purchase material quantities of tobacco on a speculative basis, and we target committed inventory levels of 80% or more of total tobacco inventory.

Industry Context

The tobacco industry continues to navigate government regulation on production and consumption, alongside evolving customer preferences, including the growth of next-generation tobacco products. The plant-based ingredients sector, while showing innovation and demand for new value-added products, is currently facing broader industry headwinds such as weakness in the consumer-packaged goods industry and tariff uncertainty. The company's assessment of no material impact from the global minimum effective tax rate (Pillar Two) legislation reflects ongoing international tax policy changes affecting multinational corporations.

Comparison to Industry Standards

• The Ingredients Operations segment's performance was impacted by 'weakness in the consumer-packaged goods industry' and 'tariff uncertainty,' suggesting underperformance relative to broader industry conditions in those areas.
• Customer demand for tobacco has remained firm despite 'significantly larger tobacco crops,' indicating a strong market position for the company's tobacco products relative to supply dynamics.
• Uncommitted tobacco inventory levels at 13% of total tobacco inventory as of September 30, 2025, are well within the company's target of 80% or more committed inventory, demonstrating effective inventory management compared to internal benchmarks.

Corporate Governance

Legal Proceedings

• A final and indisputable favorable ruling was issued in July 2025 by the Brazilian National Treasury Attorney's office, declaring a Parana value-added tax (VAT) assessment without merit and requiring the state to withdraw all claims against the company's Brazilian operating subsidiary.
• Various subsidiaries are involved in litigation and tax examinations incidental to their business activities. Management is vigorously defending these matters and does not currently expect a material adverse effect on the company's business, results of operations, or financial position, but acknowledges that an adverse resolution could be material for a particular fiscal reporting period.

Related Party Transactions

• Accounts receivable from unconsolidated affiliates totaled $114.071 million at September 30, 2025.
• Accounts payable to unconsolidated affiliates totaled $0.299 million at September 30, 2025.
• Equity in pretax earnings (loss) of unconsolidated affiliates was $(2.561) million for the three months ended September 30, 2025, and $(0.126) million for the six months ended September 30, 2025.
• Other operating sales and revenue principally include interest on advances to tobacco suppliers and dividend income from unconsolidated affiliates.

Stakeholder Impact

• Shareholders: Benefited from significant increases in net income and diluted EPS, continued dividend payments, and an active stock repurchase program. However, the material weakness in internal controls and the underperformance of the Ingredients segment could be areas of concern.
• Employees: Stock-based compensation awards continue. Restructuring activities in European tobacco operations in prior periods involved employee termination benefits.
• Customers: Tobacco customers experienced firm demand and smooth, earlier shipments. Ingredients customers may be impacted by product mix and tariff uncertainties, though the company is focusing on meeting strategic needs and converting interest into sales.
• Suppliers (farmers): The company provides seasonal advances, but higher provisions for farmer advances indicate some farmers may not fully repay, potentially affecting their financial stability.
• Creditors: The company maintains compliance with all financial covenants and has no long-term debt maturing until fiscal year 2028, indicating a stable financial position for creditors.

Next Steps

• Evaluate the impact of adopting ASU 2023-09 (Income Taxes Improvements to Income Tax Disclosures) for fiscal years beginning after December 15, 2024, and interim periods after December 15, 2025.
• Evaluate the impact of adopting ASU 2024-03 (Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures) for fiscal years beginning after December 15, 2026, and interim periods after December 15, 2027.
• Implement enhanced documentation for management review controls and validation of completeness and accuracy of key reports across the inventory process at the tobacco subsidiary to remediate the material weakness.
• Design and implement additional reports for inventory reconciliation controls at the tobacco subsidiary.
• Spend approximately $45 to $55 million over the next twelve months on capital projects for maintenance and other investments to grow and improve businesses.
• Make additional contributions of $1.6 million to pension plans during the remaining six months of fiscal year 2026.
• Recognize approximately $1.6 million in stock-based compensation expense during the remaining six months of fiscal year 2026.
• The Board of Directors will continue to exercise discretion regarding the declaration and payment of future quarterly dividends.

Key Dates

Recommendation

Universal Corporation's core Tobacco Operations continue to perform strongly, driving significant increases in net income and EPS. The favorable resolution of the Brazilian VAT assessment is a positive development. However, the decline in consolidated operating income for the quarter, the substantial underperformance and profitability challenges within the Ingredients segment, and the disclosed material weakness in internal controls introduce notable uncertainties. While the company's financial position remains solid with no near-term debt maturities and compliance with covenants, these headwinds and governance concerns warrant a cautious 'hold' recommendation until the Ingredients segment demonstrates consistent improvement and the internal control weakness is fully remediated and its effectiveness tested.

Keywords

Tobacco, Leaf Tobacco, Agri-products, Ingredients, Food Ingredients, Plant-based Ingredients, Universal Corporation, SEC Filing, 10-Q, Earnings, Financial Results, Operating Income, Net Income, EPS, Dividends, Stock Repurchase, Supply Chain, Corporate Governance, Risk Management, Sustainability, Climate Change, VAT, Brazil, Germany, Netherlands, Derivatives, Hedging, Internal Controls, FruitSmart, Silva International, Universal IngredientsShanks